Replies to post #164979 on Biotech Values

[swampboots]

ARWR up .20 and almost a double off yearly lows, are they in the Hepatitis game with credible theory?

[mcbio]

ARWR : Have you taken an updated look at ARWR, as price is creeping up for some reason?

I think price has done more than creep up and is, in fact, up substantially of late. No fundamental reason that I'm aware of. And, when things rise sharply on no fundamental reasons at all, I tend to lose interest, as I think I'm doing with ARWR. It's still cheap in grand scheme of things I suppose if their HBV RNAi drug creates some buzz in the clinic.